| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0062 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.006 | 1 |